par Bouwhuis, Marna G;Suciu, Stefan
;Kruit, Wim H;Sales, François
;Stoitchkov, K;Patel, P I;Cocquyt, Veronique;Thomas, J.;Lienard, Danielle
;Eggermont, A;Ghanem, Ghanem Elias
;European Organisation for Research and Treatment of Cancer Melanoma Group,
Référence European journal of cancer, 47, 3, page (361-368)
Publication Publié, 2011-02




Référence European journal of cancer, 47, 3, page (361-368)
Publication Publié, 2011-02
Article révisé par les pairs
Titre: |
|
Auteur: | Bouwhuis, Marna G; Suciu, Stefan; Kruit, Wim H; Sales, François; Stoitchkov, K; Patel, P I; Cocquyt, Veronique; Thomas, J.; Lienard, Danielle; Eggermont, A; Ghanem, Ghanem Elias; European Organisation for Research and Treatment of Cancer Melanoma Group, |
Informations sur la publication: | European journal of cancer, 47, 3, page (361-368) |
Statut de publication: | Publié, 2011-02 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Adult |
Aged | |
Antineoplastic Agents -- therapeutic use | |
Female | |
Humans | |
Interferon-alpha -- therapeutic use | |
Kaplan-Meier Estimate | |
Male | |
Melanoma -- blood -- mortality | |
Middle Aged | |
Neoplasm Metastasis | |
Prognosis | |
Recombinant Proteins | |
S100 Proteins -- blood | |
Skin Neoplasms -- blood -- mortality | |
Tumor Markers, Biological -- blood | |
Young Adult | |
Note générale: | Clinical Trial, Phase III |
Journal Article | |
Randomized Controlled Trial | |
Research Support, N.I.H., Extramural | |
Research Support, Non-U.S. Gov't | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0959-8049 |
info:doi/10.1016/j.ejca.2010.10.005 | |
info:pii/S0959-8049(10)00990-1 | |
info:scp/79251599240 | |
info:pmid/21087856 |